Skip to main content
    M

    Milestone Pharmaceuticals Inc (MIST)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.41
    +0.05 (+13.21%)

    Market Cap: $45.44M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Milestone Pharmaceuticals Inc (MIST) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Milestone Pharmaceuticals (MIST) has a latest price of $0.41 on Nov 17, 2026, 86.5% below its 52-week high of $3.06. Its price fell 79.3% over the past 12 months. The month-end price fell 87.0% over the 5 years through Oct 2026, a compound annual decline of 33.5%.

    Price Chart

    From May 2019 to Oct 2026, its highest month-end close was $27.15 in Jun 2019 and its lowest $0.73 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MIST with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MIST.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 61.7%, and over 6 months it fell 71.1%. The month-end price fell 71.5% over the 3 years through Oct 2026, a compound annual decline of 34.2%.

    PeriodChange
    1 month-41.0%
    3 months-61.7%
    6 months-71.1%
    12 months-79.3%
    12 months, with dividends-79.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-71.5%-34.2%
    5 years-87.0%-33.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 41.3%, and its weakest was 2020, when it fell 58.2%.

    YearCloseChange
    2026 through Oct 2026$0.73-63.9%
    2025$2.02-14.4%
    2024$2.36+41.3%
    2023$1.67-57.8%
    2022$3.96-39.5%
    2021$6.55-2.2%
    2020$6.70-58.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 46.4% below its 50-day average of $0.77 and 68.1% below its 200-day average of $1.29.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.41
    52-week high$3.06-86.5%
    52-week low$0.36+14.1%
    50-day average$0.77-46.4%
    200-day average$1.29-68.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 89.2%.

    MeasureValue
    1-year beta2.80
    Largest fall, 1 year-87.6%
    Largest fall, 3 years-89.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MIST

    What is MIST's 1-year price change?

    Milestone Pharmaceuticals's price fell 79.3% over the past 12 months. With dividends included, the 12-month total return was -79.3%.

    What is MIST's 5-year price change?

    Milestone Pharmaceuticals's month-end price fell 87.0% over the 5 years through Oct 2026, a compound annual decline of 33.5%. These figures leave out dividends.

    What is MIST's 52-week high and low?

    Milestone Pharmaceuticals's 52-week high is $3.06 and its 52-week low is $0.36. Its latest price of $0.41 on Nov 17, 2026 is 86.5% below the high.

    What is MIST's beta?

    Milestone Pharmaceuticals's 1-year beta against the S&P 500 is 2.80, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 87.6%.

    Is the MIST chart free?

    Yes. Advanced Charting for MIST is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.